FIGO STAGE IV OVARIAN CANCER 2014
Clinical trials for FIGO STAGE IV OVARIAN CANCER 2014 explained in plain language.
Never miss a new study
Get alerted when new FIGO STAGE IV OVARIAN CANCER 2014 trials appear
Sign up with your email to follow new studies for FIGO STAGE IV OVARIAN CANCER 2014, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized vaccine trial aims to train immune system to fight advanced ovarian cancer
Disease control Recruiting nowThis study is testing whether a personalized vaccine made from a patient's own immune cells can help prevent or delay the return of advanced ovarian, fallopian tube, or primary peritoneal cancer. The vaccine is designed to teach the immune system to recognize and attack cancer ce…
Matched conditions: FIGO STAGE IV OVARIAN CANCER 2014
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Could one year of treatment match two for ovarian cancer patients?
Disease control Recruiting nowThis large trial aims to see if one year of maintenance therapy is just as effective as two years for patients with advanced ovarian cancer who have specific genetic changes and responded well to initial chemotherapy. It will test two drugs, olaparib and bevacizumab, which work t…
Matched conditions: FIGO STAGE IV OVARIAN CANCER 2014
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC